skip to main content
Main Site Navigation
Top of main content

Clinical Trials Details

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Location: Carle Cancer Center - Urbana
Body site or condition: Genito - Urinary - Bladder
Department: Cancer Research

SWOG S1609 (MISMATCH)

This clinical trial studies nivolumab and ipilimumab in treating patients with rare tumors. Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread.

Apply Now